Panegyres and Graves Journal of Medical Case Reports 2012, 6:155 http://www.jmedicalcasereports.com/content/6/1/155 8. Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH: Response to intravenous immunoglobulin in Anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neuro-Oncol 2003, 63:187–190. 9. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E: Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999, 46:774–777. 10. Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD: Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2007, 109:54–57. 11. Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, Ramio- Torrenta L, Graus F: Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553–2563. 12. Bonnan M, Cabre P, Olindo S, SIgnate A, Saint-Vil M, Smadja D: Steroid treatment in four cases of anti-GAD cerebellar ataxia. Rev Neurol (Paris) 2008, 164:427–433. 13. Storstein A, Krossnes BK, Vedeler CA: Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand 2009, 120:64–67. 14. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE: Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease ad immunotherapeutics. J Neuroinflammation 2009, 69:997–1007. 15. Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG: Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 2010, 69:997–1007. doi:10.1186/1752-1947-6-155 Cite this article as: Panegyres and Graves: Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report. Journal of Medical Case Reports 2012 6:155. Page 4 of 4 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit